Can Novavax's Coronavirus Vaccine Be Valued?
The race for a COVID-19 vaccine is wildly unpredictable and full of variables.
The Top 2 Contrarian Stocks to Buy Right Now
The COVID-19 lockdown has hammered the stocks of Park Hotels & Resorts and Royal Caribbean, creating a strong buying opportunity for 2021.
Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes.
Forget Livongo: This Might Be a Stronger Telehealth Stock
Ontrak's stock price has already tripled in 2020, and there are reasons to think it might have an edge over its larger peer.
Buy Alert: Ubisoft Stock Is Heading Higher
The French video game company has promising releases coming up to boost revenue through Christmas and into 2021.
Novavax Stock Is Up on Deal With SK Bioscience
The company is adding to the already-massive production capacity it has lined up for its COVID-19 vaccine candidate.
Why in the World Is Novavax Stock Up 4,000%?
The small-cap biotech has emerged as one of the favorites in the race for a COVID-19 vaccine.
These Stocks Would Have Doubled Your Money Last Year
Axsome Therapeutics and EverQuote had two of the biggest stock gains in 2019. Are they still buys today?
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
The ruling means Moderna may have to pay royalties on its mRNA-based vaccines -- including its coronavirus candidate.
Why Was Novavax Awarded Almost $2 Billion in Free Money?
Operation Warp Speed (OWS) and the Coalition for Epidemic Preparedness Innovations (CEPI) both selected Novavax for their highest grant awards.
Beware! Your Coronavirus Stock Might Be Crushed by the FDA
Some of the companies pursuing a coronavirus vaccine will end up far more valuable than they are today -- while others might be a disaster waiting to happen.
These 2 Coronavirus Stocks Could Soar in the Second Half of 2020
Both Moderna and Vaxart are expecting data readouts that will send the stocks skyrocketing -- if the news is positive.
3 Green Flags for Novavax's Future
There are good reasons to consider this small biotech an emerging favorite in the COVID-19 vaccine race.
Better Coronavirus Stock: Altimmune vs. Vaxart
Both of these small-cap vaccine stocks are up big in 2020.
Here's the Surprising Coronavirus Stock You'll Really Want to Own
It's a small-cap biotech that specializes in vaccines.
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
Why StoneCo and bluebird bio are wonderful buys right now.
If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now
Even small investments can have a big payoff down the road.
Should I Sell Novavax Shares?
I'm up 1,340% in nine months on this investment. Is it time to take some profits?
2 Stocks That Could Make You Rich
Why Adaptive Biotechnologies and Smartsheet will be mega-cap stocks in the future.
2 Top Stocks Under $5
Here's why you might want to invest in Planet 13 and W&T Offshore.